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Hip fracture is a public health burden due to high morbidity, mortality and cost. Risk 
prediction models can aid clinical decision-making by identifying individuals at risk. 
Objective: To build risk prediction model for incident hip fracture using Weibull 
regression and compare this with Cox regression model. 
Method: The Study of Osteoporosis prospectively collected risk factors were used to 
build a risk prediction model for first hip fracture using Threshold regression with 
Wiener process. Similar predictors were fitted using Cox regression for comparison. 
Results: There were 632 first hip fractures. Age, bone density, maternal and personal 
prior fractures were significant risk factors for hip fracture. Weibull had better goodness 
of fit, higher D-statistic and R2 values than the exponential. Models did not differ in c-
index and ten-fold cross validation showed similar areas under the ROC curves. 
Conclusion: Parametric and Cox models were comparable. External validation of the 
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Chapter 1: Introduction 
The most common cause of fractures is osteoporosis. The Office of Surgeon 
General Report estimated that 1.5 million Americans suffer a fracture due to osteoporosis 
annually.1 A study by Burge et al. in 2007 has projected that by 2025, due to increase in 
lifetime risk of fracture as people live longer and the aging population grows, there will 
be more than 3 million fractures incurring $25.3 billion in costs.2 
Osteoporosis or “porous bones” is a systemic bone disease in which there is 
structural degradation of the bone and a low bone mass, resulting in brittle bones that are 
prone to low trauma or fragility fracture.3 A fragility fracture results from forces which 
would not normally produce a fracture such as falling from standing height or a vertebral 
compression fracture.4 Osteoporosis is diagnosed either by the presence of a fragility 
fracture or by the World Health Organization’s bone density criteria—when the bone 
mineral density (BMD) measured at the hip, spine or wrist is 2.5 standard deviations 
below the mean in young adult women.5 Although BMD (known also as the T-score) 
measured by dual-energy X-ray absorptiometry (DXA) is of modest predictive value it 
remains the current diagnosis and treatment evaluation criteria. Other bone components 
that determine fracture, such as the rate of bone loss and bone quality are not well 
characterized.4  
The National Osteoporosis Foundation (NOF) estimates that 10 million 
Americans have osteoporosis, of which 80% are women and 20% are men.6 Rates are 
higher for women than for men because postmenopausal estrogen deficiency is an 
important etiology of osteoporosis in women.7 Additionally, rates of osteoporosis vary by 
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race being highest in whites. Cumming et al. reported age-adjusted incidence rates in the 
U.S. to be 6.2 per 1,000 among white females, 3.8 per 1,000 among Asian females, 2.4 
per 1,000 among black females and 2.2 per 1,000 among Hispanic females.8 In all 
demographic groups, osteoporosis rate increases with age. 
The most common sites of osteoporotic fractures are the hip (43%), the spine 
(43%) and the wrist (13%).9 In addition to the economic burden of osteoporosis, hip 
fracture has serious consequences that include pain, need for surgery and loss of 
independent living. It is estimated that up to 50% of hip fracture patients experience 
reduced mobility and some do not return to pre-fracture functional level and require 
home-care.10, 11 Furthermore, there is a high mortality rate of up to 36% within the first 
year after an incident hip fracture.12 Our study focuses on hip fracture as it is the most 
severe consequence of osteoporosis in terms of public health burden. 
Osteoporosis is a chronic progressive disease and with the aging population on the 
rise the incidence of osteoporosis will increase. Even though the causes of osteoporosis 
and hip fracture are well characterized and there are opportunities for prevention and 
intervention, osteoporosis remains under-diagnosed and inadequately treated in the 
U.S.13, 14 Possible reasons include the existence of different recommendations for testing 
and initiating treatment, confusion in interpreting test results and fragmentation of health 
care.15 Increasingly, risk prediction models which take into account important clinical 
factors are used to provide a systematic approach in identifying individuals at risk of 
osteoporosis. Such a model will supplement and facilitate clinical decision-making as to 
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whether to provide lifestyle advice, to measure BMD or to initiate treatment according to 
risks of osteoporosis.  
1.1. The Cox Proportional Hazards Model 
Established four decades ago, the Cox Proportional Hazards (PH) regression is a 
standard method for analyzing survival and time-to-event data.16 The Cox regression is a 
semi-parametric method as it makes no distributional assumption on the baseline hazard 
rate (the non-parametric component) and accommodates covariates in a multiplicative 
linear regression form (the parametric component) as shown in the equation below: 
ℎ(𝑡|𝒁) = ℎ0(𝑡)𝑒𝑥𝑝(𝛽′𝒁) 
       Equation 1. Hazard rate 
where  ℎ(𝑡|𝒁) represents the hazard rate of an individual at time, t, with risk vector, Z, 
  ℎ0(𝑡) is the baseline hazard and 
  𝛽′ a parameter vector. 
With proven applications in diverse fields, it is easy to use and presents results in 















             Equation 2. Hazard ratio 
However, the Cox regression relies heavily on the PH assumption that factors 
have a constant effect on risk or hazard over time. This assumption when violated, 
especially in the presence of long follow-up, leads to incorrect inference and misleading 
conclusions. Current methods to handle non-proportional hazards assumption include 
either using the modified Cox model which “stratify” on the predictors not satisfying the 
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PH assumption or using the extended Cox model for time-dependent variables to analyze 
a time-independent predictor not satisfying the PH assumption.17 These methods are, 
however, not without limitations. In the stratified Cox model, the effect of the stratified 
predictor cannot be studied as the hazard ratio for this predictor is no longer obtainable. 
In the extended Cox model, the hazard ratios for the predictor not satisfying the PH 
assumption can be obtained at time points before and after a change in risk. This method 
may produce a complex model if the hazard ratios for the predictor not satisfying the PH 
assumption change at more than one time point or if there are several predictors in the 
model that do not satisfy the PH assumption. 
1.2. Parametric Regression Models 
 Parametric survival models make more efficient use of information, give more 
precise estimates and can be more powerful than semi-parametric method if the 
distributional form of the hazard function is known. However, when a parametric model 
is incorrectly specified it may produce consistent estimates of the wrong magnitude. 
Parametric models are characterized by the distribution of the baseline hazard function. 
This paper focuses on the exponential, the Weibull and the threshold regression models. 
1.2.1. The Exponential Model 
The exponential model has a constant hazard, λ, and the following proportional 
hazards parameterization:  
 ℎ(𝑡|𝒁) = ℎ0(𝑡)𝑒𝑥𝑝�𝛽′𝒁� = 𝜆𝑒𝑥𝑝�𝛽′𝒁� 
Equation 3. Hazard rate with exponential baseline hazard 
The survival function decreases linearly while the cumulative hazard function 
increases linearly with time. 
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1.2.2. The Weibull Model 
The Weibull has a monotonic increasing or decreasing hazard with the following 
proportional hazards parameterization: 
ℎ(𝑡|𝒁) = ℎ0(𝑡)𝑒𝑥𝑝�𝛽′𝒁� = 𝜆𝛼𝑡𝛼−1𝑒𝑥𝑝�𝛽′𝒁� 
       Equation 4. Hazard rate with Weibull baseline hazard 
where λ and α are the scale and the shape parameters respectively. When α = 1, the 
hazard shape is flat giving rise to the exponential hazard function which is thus a special 
case of Weibull. When α >1, the hazard is increasing and when α <1, the hazard is 
decreasing. 
 
1.2.3. The Threshold Regression Model 
 The Threshold regression (TR) is a parametric method that serves as a useful 
alternative to the Cox regression for analyzing time-to-event data when the PH 
assumption is violated.18 Known as the first hitting time (FHT) model, TR provides more 
information about the underlying disease than the Cox model.19 It treats the unobservable 
initial health status as a stochastic process that degrades over time to the threshold event 
or FHT. The stochastic process can be of different distributional forms. If it is a Poisson 
process, the FHT follows a gamma distribution; a Bernoulli process has a negative 
binomial distribution as FHT; and a Wiener diffusion process has inverse Gaussian as the 
FHT.20 The bivariate Wiener TR model has been used in the analysis of an AIDS clinical 
trial to investigate the effect of CD4 cell count ratio in response to antiretroviral drug 
treatment21 while the TR mixture model has been used in a clinical trial to evaluate the 
efficacy of VelcadeR in multiple myeloma.22 Additionally, the TR with a Wiener 
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diffusion process has been used in the Nurses’ Health Study to examine the effect of 
smoking and lung cancer.23 
A common stochastic process in the TR model is the Wiener process with a 
positive initial value, mean and variance parameters. When applied to osteoporotic 
fracture, the unobservable bone deterioration is modeled by a Wiener process with time 
to an incident fracture as the first hitting time of the threshold. The first hitting time of the 









     Equation 5. Inverse Gaussian probability density function 
where parameters 𝜇 is the drift of the Wiener process (i.e. the mean change in the level of 
the sample path per unit time; FHT approaches the threshold if 𝜇 < 0), 𝑦0the initial value 
of the process is positive and 𝜎2 the variance per unit time of the process is set to 1. The 
TR with Wiener process can be implemented using the stthreg package available in 
Stata.24 
 Covariates, Z, enter the model through the log link and the identity link functions 
respectively as shown in the following two equations: 
ln(𝑦0) =  𝛾0 + 𝛾1𝑍1 + ⋯+ 𝛾𝑘𝑍𝑘 = 𝒁′𝜸 
𝜇 = 𝛽0 + 𝛽1𝑍1 + ⋯+ 𝛽𝑘𝑍𝑘 = 𝒁′𝜷 
where 𝜸 and 𝜷 are vectors of regression coefficients for ln(𝑦0) and 𝜇 respectively.  
Most studies that have examined risk factors for hip fractures have used Cox 
regression with or without checking for the violation of the PH assumption.25-28 TR model 
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is available to the parametric survival models. The current objectives of the study are to 
build risk prediction model for the first hip fracture using parametric regression and to 
compare this with a similarly built Cox regression model. The resulting parametric 
prediction model can then be used to develop a risk assessment tool to aid physicians in 




Chapter 2: Methods 
2.1. Study Population 
The training data set was from the Study of Osteoporotic Fractures (SOF). The 
SOF is an ongoing multicenter observational study that evaluated risk factors for 
osteoporosis prospectively in 9,704 white women who were at least 65 years old. Age-
eligible women from community-based listings were recruited by mailings between 
September 1986 and October 1988 from four metropolitan areas in the United States to 
clinic centers in Baltimore, Maryland; Portland, Oregon; Minneapolis, Minnesota; and 
the Monongahela Valley, Pennsylvania.25 Standardized interviews and clinical 
examinations were conducted approximately every 2 years; data collected include 
anthropometric measures, vital status, DXA, cognitive and physical functions, falls, 
vision, lifestyle characteristics, family and medical histories, and other risk factors for 
fractures. Additionally, between 1997 and 1998, 662 African American women were 
recruited to this original cohort. Follow-up rates of participants exceeded 98% as efforts 
were made every quarter to ascertain fractures, falls or change in address by postcard or 
phone. The event of interest was time to first hip fracture. Hip fractures were confirmed 
by review of radiographs.25, 26 
Our analysis excluded 662 African-Americans recruited at year 10 of the SOF 
study because their risk of fracture is low (2.5 times lower than white women). In 
addition, a shorter follow-up due to late recruitment may result in a smaller number of 
women with incident hip fractures. Other exclusion criteria were women unable to walk 
without assistance, women with bilateral hip replacements, and women who reported hip 
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fracture prior to enrollment as the focus in this study was incident hip fracture and 
prospectively collected risk factors.  
2.2. Predictors 
 Risk factors for first hip fractures are well-characterized.29-39 A literature review 
was conducted and factors used in other risk assessment tools were also examined (Table 
1). Four of these seven tools did not utilize bone density. While BMD T-score was 
optional in the Fracture Index developed using SOF data, both the WHO FRAX and the 
Garvan Normogram offered optional BMD T-score or femoral neck BMD measured by 
different DXA machines. Both femoral neck and total hip BMD were included in our list 
of potential predictors as a result of their predictive value for hip fractures.49 
Twenty-four potential predictors of hip fracture measured at baseline visit or at 
visit 2 were considered as variables in the TR model: age, body mass index (BMI), 
weight change since age 25 years old, parental history of fracture, previous fracture at age 
less than 50 years, total hip and femoral neck BMD, fall and faint histories, comorbidities 
like rheumatoid arthritis, Parkinson’s disease, diabetes, stroke and hyperthyroidism, walk 
for exercise, use of medications like hormone replacement therapy, long-acting 
benzodiazepine (sleep medication) and glucocorticoids (steroids), use of supplements 
such as vitamin D and calcium, consumption of alcohol, caffeine and tobacco smoking.  
2.3. Statistical Analysis and Model Development 
 Comparisons of baseline characteristics of women with and without hip fractures 
were made using two-sample independent t-test for normally distributed continuous 
variables with equal variances, Wilcoxon rank-sum test for non-normally distributed 
continuous variables and chi-squared test for categorical variables. Univariate analyses 
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for first hip fracture were performed with and without adjustment for age. Clinically 
relevant covariates that showed association with hip fracture after adjustment for age in 
univariate analyses (p < 0.2) were included into the pool of predictors for consideration in 
the multivariate TR model for first hip fracture. The TR predictive model was built using 
the method of purposeful selection of covariates.50 A complete case analysis was 
performed using STATA version 11.2 and version 13.0 for somersd package (StataCorp, 
College Station, Texas).  
2.4. Model Comparison 
 The important factors identified from the TR model were used to fit an 
exponential, Weibull and Cox regression models. Models were compared in terms of 
predicted baseline for survival, hazard and cumulative hazard functions; for goodness of 
fit using Cox-Snell residual plots; and for discrimination using R2 statistic, D-statistic, 
Harrell’s c index of concordance and area under the Receiver Operating Characteristics 
(ROC) curves at 5 and 10 years.  
2.5. Model Validation 
To avoid over-fitting and optimism in model performance, the final model for 
first hip fracture was internally validated using ten-fold cross validation technique. The 
discriminative ability of the models was compared using area under the ROC curves at 5 




Chapter 3: Results 
3.1. Participant characteristics 
 Among the 9,704 women who participated in the study, 632 women had a first hip 
fracture. Over a mean follow-up of 8.8 years (standard deviation 6.5) the incidence rate 
of first hip fracture was 7.4 per 1000 person-years.  
 Baseline characteristics of women without hip fracture and women with first hip 
fracture were compared (Table 2). Women with a first hip fracture compared to those 
without a hip fracture were older (75.9 vs. 73.4 years, p < 0.05), had significantly lower 
body weight (63.4kg vs. 66.5kg, p < 0.05) and BMI (25.3kg/m2 vs. 26.2 kg/m2, p < 0.05), 
were shorter (158.3cm vs. 159.2cm, p < 0.05) and, gained less weight since age 25 (8.4kg 
vs. 10.9kg, p < 0.05). However, the mean weight and height at age 25 years old, and 
current waist-hip ratio did not differ significantly in these two groups of women. 
Significantly more women with a first hip fracture had a maternal history of fracture than 
those without a hip fracture (44.8% vs. 36.4%, p < 0.05). A higher percentage of women 
with a first hip fracture than women without hip fracture had a medical history of 
Parkinson’s disease (1.6% vs. 0.5%, p < 0.05) or cataract (37.6% vs. 30.4%, p < 0.05). 
Significantly more women without hip fracture than those with a first hip fracture were 
current users of oral estrogen (14.2% vs. 10.2%, p < 0.05). The two groups of women 
were similar in their duration of estrogen use and proportion taking sleep medication. 
Significantly more women with first hip fracture than those without a hip fracture were 
currently taking calcium (48.5% vs. 42.3%, p < 0.05) and vitamin D supplements (49.8% 
vs. 44.5%, p < 0.05); had ever fallen during the past year (33.6% vs. 29.3%, p < 0.05). 
More women without a hip fracture compared to those with a first hip fracture drank 
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alcohol in the past year (70.4% vs. 63.7%, p < 0.05). The two groups of women did not 
differ significantly in terms of caffeine intake, tobacco use, walk for exercise or had ever 
fainted in past 12 months. Women with a first hip fracture compared to those without hip 
fracture had significantly lower total hip (0.672 g/cm2 vs. 0.763g/cm2, p < 0.05) and 
femoral neck bone density measurements (0.584 g/cm2 vs. 0.653 g/cm2, p < 0.05). 
3.2. Predictors identified by TR model 
 The TR model identified nine significant covariates as shown in Table 3. 
For every one year increase in age, baseline health decreased by 3% (p < 0.05) while 
controlling for the other covariates. For every standard deviation (-10.2 kg) decrease in 
weight since age 25 years, baseline health decreased by 6% (p < 0.05). For every standard 
deviation (+0.141 g/day) increase in daily caffeine consumption, baseline health 
decreased by 3% (p < 0.05). A white woman with rheumatoid arthritis compared to 
another white woman without arthritis had a lower baseline health by 13.7% (p < 0.05). A 
white woman who had fallen at least once in the past 12 months compared to another 
white woman without a fall history had a lower baseline health by 10.3%. A white 
woman taking glucocorticoid in the past 12 months compared to another white woman 
not taking glucocorticoid had a lower baseline health by 22.1% (p < 0.05). 
 For every standard deviation decrease in femoral neck bone density (-0.11 g/cm2) 
the mean rate of decline in bone health was 11.7% per year (p < 0.05). A white woman 
with a history of fracture before age 50 had a mean rate of bone loss of 5.2% per year. A 
white woman with a mother’s history of fracture had a mean rate of bone loss of 6.1% per 
year (p < 0.05). 
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3.3. Kaplan-Meier plots 
 The Kaplan-Meier survival function plot is as shown in Figure 1. The plot showed 
a linear decline in survival function over time. Graphical plots of Kaplan-Meier survival 
functions for binary predictors such as maternal fracture, falls in the past 12 months, 
medical history of rheumatoid arthritis and glucocorticoid intake in the past 12 months 
showed similar linear decline as depicted in Figure 2.  
3.4. Comparison of Exponential, Weibull and Cox models 
 A table comparing the exponential, Weibull and Cox models fitted with the 
predictors obtained using the TR model is as shown in Table 4. Hazard ratios for 
predictors in the exponential, Weibull and Cox were very similar up to the first decimal 
place. Additionally, the shape parameter in the Weibull model was 1.2181 which was 
greater than one—the special case when the hazard function is exponential. 
3.5. Comparison of post-estimation plots 
 For each model post-estimation plots for baseline survival, cumulative hazard and 
hazard functions were obtained for comparison as illustrated in Figures 3, 4 and 5 
respectively. The estimated baseline Cox survival plot was a decreasing parabola that 
resembled Weibull survival function than the decreasing straight line plot of the 
exponential survival function. The estimated cumulative hazard for Cox model increased 
in a curvilinear manner that resembled the shape of the Weibull cumulative hazard than 
the increasing linear plot of the exponential cumulative hazard. The estimated hazard 




3.6. Post-estimation goodness of fit 
 A plot of estimated Nelson-Aalen cumulative hazard against Cox-Snell residuals 
should produce a 45o straight line through the origin for a model of good fit. As 
illustrated in Figure 6, Cox-Snell residuals plot for the exponential model deviated away 
from the reference line more than the Weibull model and the Cox model.  
3.7. Checking the Proportional Hazards (PH) Assumption for the Cox model 
 A global test and separate tests on each predictor in the model for PH violation 
were performed. Results in Table 5 verified that p-values for both global (p = 0.7426) and 
separate tests were all greater than 0.05. Hence there was no evidence of violation in PH 
assumption. Additionally, comparison of Kaplan-Meier observed survival curves with 
Cox predicted curves for the same binary variables were made (Figure 7). Except for yes 
response to glucocorticoid use, the observed Kaplan-Meier plots for maternal fracture, 
falls in the past 12 months and rheumatoid arthritis were very close to the predicted Cox 
curves suggesting that the PH assumption was less likely to be violated. 
3.8. Comparison of models for measures of discrimination 
Discrimination is ability of the model to usefully identify individuals at risk as 
diseased and those not at risk as non-diseased. R2 statistic, a measure of the variation 
explained by survival models, was calculated for each model (Table 6).51 The Cox model 
explained 48.51% of the variation while the Weibull model accounted for 47.92% and the 
exponential 46.01%. Royston and Sauerbrei’s D statistic which measures prognostic 
separation of survival curves with adjustment for optimism was highest for the Cox 
model (1.639), followed by Weibull (1.610), and then the exponential model (1.535).52 
The three models, however, did not differ for Harrell’s c-index, which is the probability 
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that subject pairs are concordant for predictions and outcomes with or without 
censoring.53 This was moderately high at 0.7729. A comparison of the area under the 
ROC curves using the method described by Pepe et al. at 5 and 10 years for Cox versus 
exponential and Cox versus Weibull (Table 7) further confirmed that the models did not 
differ in discriminative ability.54 
3.9. Internal cross validation 
 Internal validation is a measure of how well a model is able to predict the 
outcome for new observations that were not used in developing the model. Ten-fold cross 
validation which uses the entire data set for development and validation is a useful 
method for internal validation. This method was implemented by randomly dividing the 
data into 10 mutually exclusive subsets of equal size containing approximately the same 
number of events as illustrated in Table 8. Each subset was set aside in turn while the 
remaining 9 subsets were used for model development. A measure of prediction error can 
be estimated from the corresponding subset of observations set aside for use in predicting 
the outcome. The whole process was repeated until all 10 subsets had been used for 
prediction. Areas under the ROC curves at years 5 and 10 obtained using ten-fold cross 






Chapter 4:  Discussion 
4.1. Risk factors for first hip fracture  
 The TR model identified nine risk factors for first hip fracture from the SOF data. 
Factors that lowered the initial state of health included age, weight loss since age 25 
years, a history of falls in the past 12 months, presence of rheumatoid arthritis, increased 
daily consumption of caffeine and glucocorticoid intake. Additionally, the TR model 
revealed that femoral neck bone density, a previous fracture before age 50 years and 
maternal fracture were important in reducing health status and time to a hip fracture. 
While femoral neck bone density and previous fracture before age 50 served as 
surrogates for underlying bone loss, the risk factor maternal fracture implied genetic 
factors or heritable traits such as low BMI and low bone mass associated with small body 
build and bone size may play a role in osteoporosis.55 In contrast, only four of these 
factors (age, weight loss since age 25 years, a previous fracture before age 50 years and 
maternal fracture) were significantly associated with increased risk of hip fracture (with 
HR >1) when fitted into the Cox, the exponential and the Weibull models.  
 Age, history of maternal fracture, change in weight since age 25 years, current 
caffeine intake, prior fracture at age <50 years were risk factors identified in other 
studies.25, 26, 40 In this study the important modifiable risk factors identified were history 
of falls, increased caffeine consumption and glucocorticoid intake and weight loss since 
age 25 years. Hence prevention strategies for individuals at risk of osteoporosis include 
prevention of falls, reduction in daily caffeine intake and glucocorticoid use as well as 




 The inclusion of fall history as a risk factor in the TR model is an improvement 
over the FRAX tool, making it similar to the Garvan normogram which quantifies fall 
history. In a previous study, history of falls was identified as an important risk factor for 
hip fracture that became insignificant after adjusting for inability to rise from chair, 
spending less than 4 hours on one’s feet per day and self-rated poor health status.26 Our 
data set did not contain these adjustment variables. Additionally, there is greater 
awareness that increased risk of falls is not only a better and easier parameter to measure 
but also encompasses both frailty and sarcopenia (concepts that include weight loss, lack 
of physical activity, reduced walking speed and muscle strength) which are difficult and 
time-consuming to assess.56 
4.2. Comparison of models 
 Our results demonstrated that although the Kaplan Meier survival plot showed a 
linear decline over time, and suggested an exponential parametric model might be 
appropriate, it was good to confirm the magnitude of the shape parameter in the Weibull 
model which turned out to be slightly greater than 1. Compared to the Cox model, the 
exponential model differed more than the Weibull model in magnitudes of hazard ratios, 
baseline survival, hazard and cumulative hazard plots, extent in Cox-Snell residuals 
goodness of fit, D-statistic and R2 but not Harrell’s c-index. The exponential is a special 
case of Weibull which in turn is a special case of Cox. In this study both the Weibull and 
the exponential models were comparable to the Cox model as reflected by the areas under 
the ROC curves for the internal validation by ten-fold cross validation technique. 
 Some of the strengths of this study are the data had large numbers of events with 
comprehensive risk factors that were prospectively collected over a long follow-up 
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period. Our study showed that the Weibull model was comparable with the Cox model. It 
provided a good fit with more precise estimates when the prior hazard distribution is 
known. 
 Limitations in this study include the use of baseline risk factors and the lack of 
generalizability as the predictive model was developed using data collected from white 
women at least 65 years old who were healthy volunteers living in a community setting. 
Additionally, external validation of the predictive model is required. 
 Future work could explore the use of data from prospective studies that included 
younger women (age 50 to 64 years old), men and older women (≥ 65 years old) of other 
races, quantifying covariates such as dose and duration of glucocorticoid intake, and 
eventually bone turnover markers, when these become widely used and readily 
available.57  
 This study adds to the current literature on risk factors for first hip fracture using 
parametric models instead of the widely used Cox proportional hazards model. The TR 
model was useful in identifying surrogate markers such as BMD and previous fracture at 
age < 50 and genetic factor (maternal fracture) as underlying mechanisms for hip 
fracture. The predictive model built can be used as a risk assessment tool after external 
validation to assess and identify white women ≥ 65 years old at risk of osteoporosis for 
prevention and treatment. Modifiable risk factors identified were history of falls, intake 
of glucocorticoids and increased daily consumption of caffeine as well as weight loss 
since age 25 years. 
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Chapter 5: Conclusion 
The TR model identified nine risk factors to first hip fracture providing insights 
into the underlying disease process. Predictive model built using the Weibull and Cox 













Table 1. Overview of risk assessment tools for osteoporotic fractures. 
 








Men, women from 
Europe, N. America, 
Asia, Australia 
Age, gender, height, 
weight, previous fracture, 



















c-statistic = 0.621 











women aged 50-79 
years old 
Self-rated general health, 
race, physical activity, 
current smoking, previous 
fracture after 55 y/o, 
parental history of fracture 
after 40 y/o, current 
corticosteroid use, diabetic 
control, age, weight, height 
--11 factors 
 








SOF data: US healthy 
white postmenopausal 
women >65 years old 
Age, previous fracture after 
50 y/o, mother’s history of 
hip fracture after 50 y/o, 
weight (≤ 125pds) , current 





total hip T-score 
5 year hip 
fracture risk and 
5 year vertebral 
fracture risk 
ROC AUC 0.714 
without BMD, 0.766 
with BMD. 
Externally validated 
using EPIDOS  data 
from France in 
postmenopausal 
women ≥75 years old 
AUC: area under the curve, NA: not available, y/o: years old, ROC: Receiver Operating Characteristic curve, EPIDOS: European Patent 
Information and Document Service fracture study  
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Table 1. Overview of risk assessment tools for osteoporotic fractures (continued). 









DOES data (Dubbo 
Osteoporosis 
Epidemiology Study) 
Men and women >60 
years old 
Sex, age, fracture since 50 









5- and 10-yr 










prospective study in 
Sweden in 3 rural 
primary health care 
districts 
Women ≥70 years old 
Age, weight (<132lb or 
60kg), ability to rise from 
chair w/o using arms, any 
fracture after 40 y/o 
--4 factors 
 










cohort study in 
England and Wales 
Men and women 30-
85 years old 
Age, sex, race, smoking, 
alcohol, diabetes, parental 
history of fracture, living in 
institution, previous 
fracture, history of falls, 10 
disease conditions, taking 
anticonvulsants, 
antidepressants, steroid 
tablets, estrogen, BMI 
--25 factors/questions 
 
No Calculates 1 to 
10-yr (user’s 
choice) risk of 













Women ≥ 45 years old 
Age, weight, current 
estrogen use (yes/no) 
--3 factors 
No Any fracture 0.63 (0.55-0.71)38 
AUC: area under the curve, NA: not available, y/o: years old, ROC: Receiver Operating Characteristic curve, ORAI: Osteoporosis Risk Assessment Instrument
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Table 2. Baseline characteristics of women without hip fracture versus women with one 
hip fracture. 
Characteristics 
Women with no 
incident hip 
fracture  
(N = 9,072) 
Women with one 
incident hip 
fracture  
(N = 632) 
P-
value 
Age (years) 73.4 ± 5.1 75.9 ± 5.5 0.000 
Anthropometric measures               
Weight (kg) 66.5 ± 11.9 63.4 ± 11.2 0.000 
Weight at age 25 (kg) 56.2 ± 6.8 55.9 ± 6.8 0.307 
Weight gain since age 25 (kg) 10.9 ± 10.3 8.4 ± 9.9 0.000 
Height (cm) 159.2 ± 5.8 158.3 ± 6.0 0.000 
Height at age 25 (cm) 162.6 ± 5.7 162.6 ± 5.8 0.789 
BMI (kg/m2) 26.2 ± 4.4 25.3 ± 4.2 0.000 
Waist-hip ratio 0.831 ± 0.070 0.835 ± 0.073 0.217 
Parental history (% Yes)               










Medical history (%Yes)               






























Medication history               





No. of years on oral estrogen 8.5 ± 9.2 7.3 ± 8.7 0.059 





Lifestyle               
Weekly calcium intake from food (g) 5.0 ± 3.0 4.8 ± 2.8 0.038 










No. of years taken vitamin D 11.2 ± 12.5 10.3 ± 11.7 0.151 
Current daily caffeine intake (g) 0.16 ± 0.14 0.17 ± 0.14 0.063 





No. of drinks/week in past 30 days 1.78 ± 3.75 1.85 ± 4.02 0.108 





Pack year smoked 27.0 ± 23.8 27.2 ± 25.3 0.849 





No. of blocks walked per day for exercise 12.0 ± 10.2 11.3 ± 9.7 0.485 





No. of falls last year 0.49 ± 1.55 0.52 ± 0.99 0.036 










Table 2. Baseline characteristics of women without hip fracture versus women 
with one hip fracture (continued). 
 
              
Characteristics 
Women with no 
incident hip 
fracture 
 (N = 9,072) 
Women with one 
incident hip 
fracture  
(N = 632) 
P-value 
Bone density measurements               
Total hip BMD (g/cm2) 0.763 ± 0.130 0.672 ± 0.111 0.0000 
Femoral neck BMD (g/cm2) 0.653 ± 0.110 0.584 ± 0.093 0.0000 
Intertrochanteric BMD (g/cm2) 0.891 ± 0.159 0.783 ± 0.137 0.0000 
Trochanteric BMD (g/cm2) 0.562 ± 0.102 0.488 ± 0.085 0.0000 
Calcaneal BMD (g/cm2) 0.431 ± 0.110 0.360 ± 0.090 0.0000 





Table 3. Factors identified for first hip fracture using threshold regression model with 
Wiener diffusion process (N = 5,336, number of hip fractures = 361 hip fracture cases). 
 
Variable Coef. (lny0) Std. Err. P-value 
Age (years) -0.0304 0.0029 0.000 
Weight loss since age 25 (-10.2 kg)* -0.0625 0.0173 0.000 
Told by doctor have rheumatoid arthritis (Y/N) -0.1479 0.0338 0.000 
Fall in past 12 months (Y/N) -0.1091 0.0334 0.001 
Daily caffeine intake (+0.141 g/day)* -0.0300 0.0150 0.045 
Taken steroid past 12 months (Y/N) -0.2500 0.0685 0.000 
Constant 3.4164 0.2178 0.000 
    
 
Coef. (mu) Std. Err. P-value 
Femoral neck BMD (-0.11 g/cm2)* -0.1166 0.0124 0.000 
Prior fracture before age 50 (Y/N) -0.0519 0.0206 0.012 
Mother's history of fracture (Y/N) -0.0611 0.0200 0.002 
Constant 0.4373 0.0178 0.000 
        
 
* per standard deviation decrease or increase for continuous variable 
BMD: bone mineral density 





     Table 4. Comparison of Exponential, Weibull and Cox models for first hip fracture (N = 5,336, number of hip  







Variable Haz. Ratio P-value   Haz. Ratio P-value   Haz. Ratio P-value 





Femoral neck BMD (-0.11g/cm
2









































   
0.1973 0.000 
   
p, shape parameter 
   
1.2181 
    
1/p 
   
0.8210 
    
 
     * per standard deviation decrease or increase for continuous variable 
                    BMD: bone mineral density 




                Table 5. Proportional Hazards Assumption tests for predictors in the Cox model. 
 
PH test for risk factors in the Cox model Chi2 P-value 
Age (years) 0.02 0.8781 
Femoral neck BMD (-0.11g/cm
2
)* 1.63 0.2013 
Weight loss since age 25 (-10.17kg)* 0.00 0.9708 
Prior fracture before age 50 (Yes vs. No) 0.02 0.8906 
Mother's history of fracture (Yes vs. No) 0.73 0.3921 
Fall in past 12 months (Yes vs. No) 1.66 0.1977 
Told by doctor have rheumatoid arthritis 0.25 0.6138 
Daily caffeine intake (+0.141g/day)* 0.56 0.4543 
Taken steroid past 12 months (Yes vs. No) 0.72 0.3963 
Global test 5.97 0.7426 
* per standard deviation decrease for continuous variable 
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      Table 6. A comparison of Cox versus Exponential and Weibull models for measures of discrimination. 
 
  Cox 95% CI Exponential 95% CI Weibull 95% CI 
R2 48.51 (42.30, 57.06) 46.01 (39.65, 54.34) 47.92 (41.50, 56.39) 
D statistic 1.639 (1.550, 1.728) 1.535 (1.450, 1.620) 1.610 (1.523, 1.697) 
Harrell's c 0.7729 (0.7488, 0.7970) 0.7729 (0.7487, 0.7970) 0.7729 (0.7488, 0.7971) 







Table 7. A comparison of AUCs at 5 and 10 years: Cox versus exponential and Cox versus Weibull models for first hip fracture. 
AUC comparison Cox 95% CI Exponential 95% CI p-value Weibull 95% CI p-value N=5336 
Year 5 0.7883 (0.7540, 0.8226) 0.7886 (0.7544, 0.8229) 0.65 0.7885 (0.7543, 0.8228) 0.39 Ne=151 
Year 10 0.7596 (0.7297, 0.7895) 0.7599 (0.7299, 0.7899) 0.56 0.7598 (0.7305, 0.7891) 0.35 Ne=254 
                    
AUC: area under the curve 
CI: confidence interval 
N: total sample size 














  Table 8. An illustration showing the random division of data into 10 mutually exclusive subsets of equal size for use in 10-fold  











Table 9. Ten-fold cross validation AUC results: Weibull and exponential models for first hip fracture. 
 
 
Year Exponential 95% CI Weibull 95% CI p-value 
5 0.7804 (0.7453, 0.8156) 0.7795 (0.7442, 0.8148) 0.17 
10 0.7542 (0.7239, 0.7844) 0.7544 (0.7242, 0.7846) 0.58 
 
          
   AUC: area under the curve 
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Figure 2. Kaplan-Meier survival function plots for categorical predictors—maternal fracture, history of falls in the past 12 months, 













0 5 10 15 20
Time (years)
Mom's fracture: NO Mom's fracture: YES











0 5 10 15 20
Time (years)
Fall: NO Fall: YES











0 5 10 15 20
Time (years)
Rheu.Arthritis:NO Rheu.Arthritis:YES











0 5 10 15 20
Time (years)
Steroid use:NO Steroid use:YES
Kaplan-Meier estimated survival function for intake of glucocorticoid (steroid)
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Model: Age, FN BMD, prior fract, mom's fract, wt loss, arthritis, fall, caffeine, steroid
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Cumulative hazard of Cox-Snell residuals for Exponential model
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Figure 7. A comparison of Kaplan-Meier and Cox survival functions for binary predictors—maternal fracture, history of falls in the 
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